Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.
about
TAMH: A Useful In Vitro Model for Assessing Hepatotoxic MechanismsComparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.Differential regulation of mitogen-activated protein kinase pathways by acetaminophen and its nonhepatotoxic regioisomer 3'-hydroxyacetanilide in TAMH cells.Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models.Identification of the Additional Mitochondrial Liabilities of 2-Hydroxyflutamide When Compared With its Parent Compound, Flutamide in HepG2 Cells.IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.Toxicogenomic biomarkers for liver toxicityComparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injuryOvercoming Chloroquine Resistance in Malaria: Design, Synthesis, and Structure-Activity Relationships of Novel Hybrid Compounds.Genetical toxicogenomics in Drosophila identifies master-modulatory loci that are regulated by developmental exposure to leadMitochondrial gene profiling: translational perspectives.Managing the challenge of chemically reactive metabolites in drug development.The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.Nitroaromatic compounds: Environmental toxicity, carcinogenicity, mutagenicity, therapy and mechanism.Oxidation potentials of N-modified derivatives of the analgesic flupirtine linked to potassium KV 7 channel opening activity but not hepatocyte toxicity.Anticancer potential of 3-(arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives.Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and Its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips.The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p.
P2860
Q28818435-158160E1-5B78-4C8F-A08A-791058EC4C47Q30010969-70DDD59B-50BE-465E-9FEA-8BC1E9891AA7Q33917959-A1BC4FEC-CB29-44C0-80FC-A0C614C64F3EQ34500223-97607B17-3D6C-47F0-958A-F45610C79B0AQ34534111-C08E09E8-2BD8-4BD0-B33F-EC7C37C1F8C6Q35037290-14F947DC-0E55-4FF8-BDD4-EC628C0415B0Q35633882-2A6FAC38-9759-443E-B852-892367A6E7BCQ36717800-74768236-FA8F-4FE2-8D3E-14F24E841B5BQ36888033-AC26F89E-7974-4C4C-8F55-B8556FC65B44Q37463613-4A33B91C-12C9-4848-BB3D-E3A9E7A0E1A7Q37618225-0B6B36E2-52F5-4D73-B7F7-C1338483A725Q37860142-F40D4160-71A4-4ED6-9EF4-8C247DB946ACQ37979858-7DF6F737-42B5-4055-9434-62C901C196E5Q38188523-6DE93A09-D21E-4D03-8A02-054D3CA011D4Q38940792-8637A7D3-C11D-46EB-B86F-9ACBF79496E7Q39380402-88478FE7-B156-44A4-91CF-113324D0B9BFQ40025713-62E3D6B9-E48D-4702-8757-EAB205F49642Q41841000-9829DF65-0399-4102-B5C5-871A98A5F7EFQ42716716-CF5D341E-9794-41A0-9D37-E2987B36B106Q47116057-463C4AAE-FAAD-4C81-B1AE-2A6B955DA10D
P2860
Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@ast
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@en
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@nl
type
label
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@ast
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@en
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@nl
prefLabel
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@ast
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@en
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@nl
P2093
P2860
P356
P1476
Comparison of the cytotoxicity ...... using toxicogenomic screening.
@en
P2093
Frederico M Farin
Han Kiat Ho
Kevin J Coe
Libby Woodke
Nelson Fausto
Peter Rademacher
Richard P Beyer
Sidney D Nelson
Stephen R Plymate
Theo K Bammler
P2860
P304
P356
10.1021/TX7001349
P577
2007-08-17T00:00:00Z